Omanta was founded by Alfredo Gonzalez, Ranad Humeidi in 2026.

Who are Omanta's investors?

Omanta's investors include Y Combinator, Act One Ventures, Blast.Club, Broom Ventures, Founders Factory, Metsu Capital, Outliers VC, Pioneer and 1 more.

Where is Omanta headquartered?

Omanta is headquartered in San Francisco, US.

Omanta

YC S26

San Francisco, US · Founded 2026 · 6 employees · 9 known investors

Find your way into Omanta

Paths you didn't know you had: your email and LinkedIn already hold routes to the Omanta team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Omanta provides personalized scientific research support for complex disease cases, assigning PhD-level teams to build detailed molecular profiles from a patient's genomic, RNA, and protein data. It cross-references each patient's molecular profile against an internal reference cohort and biomedical literature to model therapeutic options and produce a research roadmap that informs the clinical team's decisions.</parameter> <parameter name="founders">[]

Also known as ClinSIGHT AI Corporation · ClinSIGHT AI

AI & Machine Learning Biotech Digital Health Healthtech Artificial Intelligence Healthcare Health & Wellness OncologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S26)

Omanta was founded in 2026 by Alfredo Gonzalez and Ranad Humeidi.

Alfredo Gonzalez Founder & Chief Executive OfficerCo-founder and CEO of Omanta, which provides personalized scientific research support for complex disease cases. He holds a PhD in cancer bioinformatics from UCLA, conducted biomedical research at the Broad Institute and Harvard, and has over a decade of experience in personalized medicine, including work on personalized vaccines, immunotherapies, and radioligands.

Ranad Humeidi Founder and Chief Scientific OfficerRanad Humeidi is the Founder and Chief Scientific Officer of Omanta, which provides personalized scientific research support for complex disease cases. She holds a PhD in Chemical Biology from Harvard and has experience identifying a druggable mechanism in ulcerative colitis that led to a GSK collaboration, directing a rare cancer research program for an individual patient, and developing strategies for complex patients whose standard treatment options had been exhausted.

Investors · 9

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us